Trial Profile
A Randomized, Double-Blinded, Placebo-Controlled Exploratory Study of Daikenchuto (TU-100) in Patients With Functional Constipation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2013
Price :
$35
*
At a glance
- Drugs TU 100 (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 May 2013 Actual initiation date changed from 1 Jun 2011 to 1 Sep 2011 as reported by ClinicalTrials.gov.